Halozyme Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,853	4,859	3,833	6,385	4,179	4,222
Market Cap Growth	19.62%	26.76%	-39.97%	52.80%	-1.03%	115.82%
Enterprise Value	7,466	5,553	4,655	7,420	4,226	4,261
Last Close Price	58.33	38.47	28.94	46.60	29.61	31.92
PE Ratio	15.47	13.70	17.34	38.06	14.05	44.66
PS Ratio	7.41	5.99	5.89	11.66	12.76	21.54
PB Ratio	18.28	16.72	58.26	45.31	28.73	38.17
P/TBV Ratio	-	-	-	-	28.73	38.17
P/FCF Ratio	15.29	12.99	13.08	32.70	18.99	108.87
P/OCF Ratio	15.08	12.70	12.57	32.04	18.90	103.95
EV/Sales Ratio	8.20	6.85	7.15	13.54	12.91	21.74
EV/EBITDA Ratio	12.39	11.09	14.22	26.60	20.63	39.89
EV/EBIT Ratio	13.81	12.61	17.43	30.89	20.74	40.33
EV/FCF Ratio	16.66	14.84	15.88	37.99	19.20	109.86
Debt / Equity Ratio	3.05	4.22	18.27	9.07	4.47	2.66
Debt / EBITDA Ratio	1.87	2.42	3.59	4.54	3.15	2.71
Debt / FCF Ratio	2.56	3.28	4.10	6.55	2.95	7.59
Asset Turnover	0.57	0.54	0.46	0.45	0.53	0.47
Inventory Turnover	1.65	1.77	2.36	2.67	2.04	1.72
Quick Ratio	1.25	6.50	5.07	4.54	7.10	1.11
Current Ratio	1.59	7.80	6.64	5.65	7.91	1.32
Return on Equity (ROE)	124.50%	198.42%	222.07%	110.23%	231.44%	106.33%
Return on Assets (ROA)	21.24%	18.16%	11.89%	12.28%	20.47%	15.74%
Return on Invested Capital (ROIC)	44.20%	34.03%	20.93%	27.92%	105.98%	108.82%
Return on Capital Employed (ROCE)	53.30%	28.70%	21.00%	16.90%	27.90%	91.00%
Earnings Yield	6.46%	7.30%	5.77%	2.63%	7.12%	2.24%
FCF Yield	6.54%	7.70%	7.65%	3.06%	5.27%	0.92%
Buyback Yield / Dilution	3.31%	3.56%	4.56%	4.21%	-3.77%	1.99%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.